floaters
发表于 2025-3-26 21:46:08
Maaja Vadi,Harald Lepiska wide geographic area and using heterogeneous resources. Current implementations allow the definition and controlled execution of complex and long lived business processes as the basis for an enterprise-wide collaborative system but, in most cases, the autonomy of the users is greatly restricted du
顽固
发表于 2025-3-27 02:08:26
available extend the potential for realism of these exercises. In addition, with the use of hypermedia methodologies, it is now possible to link components of a clinical case — e.g., the tests, the images (or sounds or tracings) of the actual results, or the textual descriptions of findings — with o
继而发生
发表于 2025-3-27 06:12:05
Tiiu Paas,Helen Poltimäefollow-up, to store medical knowledge and to provide facilities for decision making at the level either of the individual patient or of the population followed up. An integrated approach, progressively implemented in the ARTEMIS system since 1975, is described for the computerized management of hype
软膏
发表于 2025-3-27 12:38:57
Jaan Masso,Priit Vahterfollow-up, to store medical knowledge and to provide facilities for decision making at the level either of the individual patient or of the population followed up. An integrated approach, progressively implemented in the ARTEMIS system since 1975, is described for the computerized management of hype
harbinger
发表于 2025-3-27 14:32:32
Hilmar Þór Hilmarsson Ph.D.vention coding system as well as the recording of essential patient administrative and medical information. The aim of the program is to improve patient care and research, stimulate study projects between cooperating centers, and enhance the efficient management of departmental resources. The coding
extinct
发表于 2025-3-27 21:28:03
http://reply.papertrans.cn/47/4668/466728/466728_36.png
Invertebrate
发表于 2025-3-28 00:21:01
http://reply.papertrans.cn/47/4668/466728/466728_37.png
transient-pain
发表于 2025-3-28 03:26:19
Jaan Masso,Tõnu Roolaht,Urmas Varblanedies are usually not able to provide a full picture of the benefit-risk-profile of a new drug for several reasons which increases the likelihood that adverse drug reactions will occur after marketing approval that were not observed during phase III of clinical development. The knowledge gap regardin
resistant
发表于 2025-3-28 07:30:58
http://reply.papertrans.cn/47/4668/466728/466728_39.png
Ingenuity
发表于 2025-3-28 13:42:39
http://reply.papertrans.cn/47/4668/466728/466728_40.png